Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Invested Capital (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Invested Capital for 10 consecutive years, with $16.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 5.82% to $16.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $16.7 million, a 5.82% decrease, with the full-year FY2024 number at $17.1 million, down 17.56% from a year prior.
  • Invested Capital was $16.7 million for Q3 2025 at KORU Medical Systems, down from $16.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $37.8 million in Q1 2021 to a low of $16.6 million in Q1 2025.
  • A 5-year average of $26.9 million and a median of $28.5 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 211.43% in 2021, then crashed 35.35% in 2024.
  • KORU Medical Systems' Invested Capital stood at $36.5 million in 2021, then fell by 12.83% to $31.8 million in 2022, then plummeted by 34.69% to $20.8 million in 2023, then dropped by 17.56% to $17.1 million in 2024, then fell by 2.51% to $16.7 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Invested Capital are $16.7 million (Q3 2025), $16.8 million (Q2 2025), and $16.6 million (Q1 2025).